Search Results 311-320 of 14769 for albumin

1. Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma (HIMALAYA) - Mayo Clinic

   Albumin ≥.8 g/dL. International normalized ratio (INR) ≤1.6. Note: INR prolongation due to anticoagulants for prophylaxis (e.g., atrial fibrillation) in ...

2. Sorafenib for Hepatopulmonary Syndrome - Mayo Clinic

   Albumin ≥ 2.8 g per deciliter; Total bilirubin ≤ 3 mg per deciliter; Alanine aminotransferase and aspartate aminotransferase ≤ 5 times the upper limit of ...

3. Publications - Brad S. Karon, M.D., Ph.D. - Mayo Clinic

   Heparin Interference with Sodium and Albumin Assays. Clin Chem. 1997; 43(4):697-698. View PubMed; Shi Y, Karon BS, Kutchai H, Thomas DD. Phospholamban ...

4. Study to Evaluate the Safety and Effectiveness of BMS-986036 in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Cirrhosis - Mayo Clinic

   Serum albumin < 3.5 g/ dL;; Platelet count < 100 × 103/μL;; International normalized ratio (INR) > 1.4, unless due to therapeutic anticoagulation;; Fasting ...

5. Futibatinib and Pembrolizumab for the Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer - Mayo Clinic

   - Albumin >= 2.5 g/dL (=< 15 days prior to registration) - Alanine aminotransferase (ALT) and aspartate transaminase (AST) =< 2.5 x upper limit of normal ...

6. ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer - Mayo Clinic

   ... albumin ≥3 g/dL). Recovered from all toxicities to Grade 1 or less by NCI CTCAE v4.03 (except alopecia or peripheral neuropathy that may be Grade 2 or less) ...

7. Drugs and Supplements that Start with V - Mayo Clinic

   Albumin, iodinated i-131 (intravenous route) · Von willebrand factor recombinant (intravenous route). Vonjo. Also known as. Pacritinib (oral route) · Vonoprazan ...

8. Phase I Study Of BL0020, A Novel Anti-tumor Drug, In Adult Subjects With Advanced Solid Tumors - Mayo Clinic

   Those who received blood transfusion, albumin, recombinant human thrombopoietin, or colony-stimulating factor therapy within 2 weeks prior to screening. 15 ...

9. First-in-Human Study of KO-947 in Non-Hematological Malignancies - Mayo Clinic

   Serum albumin ≥ 2.8 g/dL. Acceptable liver function: Bilirubin ≤ 1.5 times upper limit of normal (x ULN); if liver metastases are present, then ≤ 2 x ULN ...

10. Clinical Biochemistry & Immunology - Laboratory Medicine and Pathology

    Clinical Biochemistry & Immunology provides analysis of biological fluids or tissues for specific chemical constituents or physiologic processes.